Antipsychotic Prescribing Pattern in Elderly Patients with Psychiatric Disorders

Authors

  • Grace Ann Varghese Seven Hills College of Pharmacy, Tirupati, Andhra Pradesh, India
  • K Mansekhar Seven Hills College of Pharmacy, Tirupati, Andhra Pradesh, India
  • S Chethana Seven Hills College of Pharmacy, Tirupati, Andhra Pradesh, India
  • S Disha Rani Seven Hills College of Pharmacy, Tirupati, Andhra Pradesh, India
  • G Roop Sai Seven Hills College of Pharmacy, Tirupati, Andhra Pradesh, India

Abstract

The elderly people are more prone to develop psychiatric disorders due to a number of factors like changes in the brain, other illnesses etc. They represent the most vulnerable group as they are most sensitive to the effects of drugs and are at increased risk of developing adverse drug reactions. This warrants the need to make the prescribers cautious about rational prescribing of antipsychotics to the Elderly. The study included elderly inpatients and outpatients visiting psychiatry ward with psychiatric disorders. Descriptive weighed analysis was performed to determine the prescribing practices of atypical antipsychotics. Among the 70 patients who were involved in the study, 36 patients were diagnosed with neurotic disorders and 30 patients were diagnosed with psychotic disorders and 4 were diagnosed with degenerative disorders (dementia). In our study neurotic disorders (51%) were the major diagnosis. 6 different atypical antipsychotic drugs were prescribed to the patients suffering from different psychiatric disorders. Among them olanzapine (43%) was the most commonly prescribed drug, followed by quetiapine (30%), risperidone (21%), clozapine (3.2%), lurasidone (1%),  and aripiprazole (1%). This study has concluded that atypical antipsychotics are preferred over typical antipsychotics and Olanzapine is the most commonly prescribed drug for the elderly patients suffering from psychiatric disorders. On comparison of the prescribed daily doses with the maximum daily dose we have observed that the prescribed daily doses for the elderly patients were well within the maximum daily dose of the drugs and in our study no adverse drug reactions were reported in the study subjects that were involved.

Keywords:

Antipsychotics, prescribing patterns, elderly patients, psychiatric disorders, atypical antipsychotics.

DOI

https://doi.org/10.25004/IJPSDR.2019.110403

References

Kar SS, Pardhan HS, Mohanta GP. Concept of essential medicine and rational use of public health. Indian Journal of Community Medicine. 2010; 35(1): 10-3.

World Health Organisation (WHO). Expert Committee. Geneva: WHO; 1977. Report of a WHO 1977. The Selection of Essential Drugs; PP: 7-35. WHO Technical Report Series, No.615.

Dilip C, Dinesh KMK, Divya R, Lisa MM. Prescription Monitoring Study of Antipsychotic Drugs in Geriatric Population at Tertiary Level Referral Hospital in Rural India. Indian Journal of Pharmacy Practice. 2012; 5(3):49-52.

Piparva KG, Parmar DM, Singh AP, Gajera MV, Trivedi HR. Drug utilization study of psychotropic drugs in outdoor patients in a teaching hospital. Indian J Psychol Med. 2011;33(1):54-8.

Deshmukh SA, Shaikh TS. Evaluation of psychotropic drugs use pattern among out patients attending psychiatry department at government medical college and hospital, Nagpur: A cross sectional study. Int J Pharm Bio Sci. 2012;3(3):428-36.

Sheldon TA. Problems of using modeling in the economic evaluation of health care. Health Econ 1996;5:1–11.

Pradhan SC, Shewade DG, Shashindran CH, Bapna JS. Drug utilization studies. National Med J India. 1988;1:185–189.

Vijaykumar TM, Sathyavati D, Subhashini T, Grandhi S, Dhanaraju MD. Assessment of prescribing patterns/trends and rationality of drug prescribing. International Journal of pharmacology, 2011; 7(1): 140-143.

Bjerrum L, Larsen J, Søndergaard J. [Drug prescription patterns in general practice. Extent, problems and possibilities of improvement]. Ugeskr Laeger. 2002 Nov 4;164(45):5273-7.

World Health Organization. Promoting rational use of medicines: core components - WHO policy perspectives on medicines. 2002.

WHO Model Formulary. Geneva: WHO press; 2004.

Kumar S, Chawla S, Bimba HV, Rana P, Dutta S, Kumar S. Analysis of Prescribing Pattern and Techniques of Switching Over of Antipsychotics in Outpatients of A Tertiary Care Hospital in Delhi: A Prospective, Observational Study. J Basic Clin Pharma 2017; 8: 178-184.

Patted UH, Hema NG, Nagaraj AKM. Antipsychotics in schizophrenia: a retrospective study of drug utilization pattern in outpatient department of psychiatry at a tertiary care hospital. Int J Basic Clin Pharmacol 2018; 7: 167-72.

Rode SB, Salankar HV, Verma PR, Sinha U, Ajagallay RK. Pharmacoepidemiological survey of schizophrenia in Central India. Int J Res Med Sci. 2014; 2: 1058-62.

Paul PK, Konwar M, Das S. Prescribing pattern of antipsychotic drugs in a tertiary care hospital of Assam. International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6(4): 435-437.

Roopadevi HS, Nagabushan K, Ramesh KN. Pattern of Psychotropic prescription in a tertiary care hospital: A critical analysis. Asian Journal of Pharmaceutical and Clinical research. 2015; 8(5): 252-255.

Piparva KG, Parmar DM, Singh AP, Gajera MV, Trivedi HR. Drug utilization study of psychotropic drugs in outdoor patients in a teaching hospital. Indian J Psychol Med. 2011 Jan;33(1):54-8.

Findling RL, Pathak S, Earley WR, Liu S, DelBello M. Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: A 26-week,open-label, continuation study. J. Child Adolesc. Psychopharmacol. 2013; 23:490–501.

Published

30-07-2019
Statistics
Abstract Display: 542
PDF Downloads: 811
Dimension Badge

How to Cite

“Antipsychotic Prescribing Pattern in Elderly Patients With Psychiatric Disorders”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 11, no. 4, July 2019, pp. 120-5, https://doi.org/10.25004/IJPSDR.2019.110403.

Issue

Section

Research Article

How to Cite

“Antipsychotic Prescribing Pattern in Elderly Patients With Psychiatric Disorders”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 11, no. 4, July 2019, pp. 120-5, https://doi.org/10.25004/IJPSDR.2019.110403.